NCT00157586View on ClinicalTrials.gov

Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND)

PHASE3CompletedINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

June 30, 2008

Conditions
Type 2 Diabetes
Interventions
DRUG

Delapril, Delapril-Manidipine Fixed combination

Trial Locations (8)

20089

Humanitas Institute - Endocrinology and Diabetologic Unit, Rozzano

24020

Clinical Research Center for Rare Diseases, Ranica

24036

ASL of Ponte San Pietro - Diabetologic Unit, Ponte San Pietro

24058

Hospital of Romano di Lombardia - Diabetologic Unit, Romano di Lombardia

24068

"Hospital Bolognini - Medicine Unit", Seriate

24128

"Hospital Ospedali Riuniti di Bergamo - Diabetologic Unit", Bergamo

"Hospital Treviglio Caravaggio - Diabetologic Unit", Treviglio

Unknown

Department of Endocrinolgy, Diabetes and Metabolic Disease - University Medical Center, Ljubljana

All Listed Sponsors
lead

Mario Negri Institute for Pharmacological Research

OTHER

NCT00157586 - Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) | Biotech Hunter | Biotech Hunter